Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation

Clinical Pharmacology and Therapeutics
B M KerrR H Levy

Abstract

On the basis of drug interactions with carbamazepine epoxide, it has been hypothesized that valproic acid and valpromide are inhibitors of epoxide hydrolase, but the role of epoxide hydrolase in these interactions has not been clearly established. In this study, therapeutic concentrations of valproic acid (less than 1 mmol/L) and valpromide (less than 10 mumol/L) inhibited hydrolysis of carbamazepine epoxide and styrene oxide in human liver microsomes and in preparations of purified human liver microsomal epoxide hydrolase. Valpromide (KI = 5 mumol/L) was 100 times more potent than valproic acid (KI = 550 mumol/L) as an inhibitor of carbamazepine epoxide hydrolysis in microsomes. After administration of carbamazepine epoxide to volunteers, the transdihydrodiol formation clearance was decreased 20% by valproic acid (blood concentration approximately 113 mumol/L) and 67% by valpromide (blood concentration less than 10 mumol/L). For both valproic acid and valpromide, a striking similarity exists between in vitro and in vivo inhibitory potencies. Valproic acid and valpromide are the first drugs known to inhibit microsomal epoxide hydrolase, an important detoxification enzyme, at therapeutic concentrations.

Citations

Jun 1, 1994·British Journal of Clinical Pharmacology·M PirmohamedB K Park
Jul 10, 2002·Clinical Pharmacokinetics·James W McAuley, Gail D Anderson
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Christophe Morisseau, Bruce D Hammock
May 10, 2012·Expert Opinion on Drug Metabolism & Toxicology·Yin Cheong WongZhong Zuo
Jun 11, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Francesca ToselliMartin A Hayes
Jun 1, 1997·Environmental Health Perspectives·J Seidegård, G Ekström
Feb 25, 2000·Therapeutic Drug Monitoring·P N Patsalos
Apr 3, 2008·Pest Management Science·Christophe Morisseau, Bruce D Hammock
Sep 25, 2014·Archives of Toxicology·Ahmed A El-Sherbeni, Ayman O S El-Kadi
Jun 1, 1990·British Journal of Clinical Pharmacology·D K RobbinsS L Chang
Jan 1, 1994·Critical Reviews in Toxicology·S J Sumner, T R Fennell
Jan 1, 1995·Clinical and Experimental Immunology·R J Riley, J S Leeder
Feb 18, 1994·Pharmacy World & Science : PWS·M BialerS Hadad
Jul 29, 1998·The Annals of Pharmacotherapy·S I Chang, J W McAuley
Dec 13, 2000·Biopharmaceutics & Drug Disposition·D M ReithM J Eadie
Mar 5, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Maria RosaHugues Chanteux
Apr 1, 1995·Journal of Clinical Psychopharmacology·S K GuthrieD E Hilleman
Nov 8, 2001·Journal of Clinical Pharmacology·K VenkatakrishnanD J Greenblatt
Dec 1, 1996·Seminars in Cutaneous Medicine and Surgery·L E Shapiro, N H Shear
Dec 5, 2020·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·D BoelsR Bouquié
Feb 1, 1994·The Journal of Pediatrics·S G KahlerJ V Leonard
Jul 9, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ying FangJinhai Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.